Back to home
NOVN logo

Is NOVN (Novan, Inc.) Halal or Haram?

NASDAQ Capital MarketHealthcareBiotechnology$2.6M2026-02-24
NOVN is Haram (Not Halal)2/4 screens passed

While Novan's biotechnology focus is inherently halal, the company's financial structure renders it non-compliant according to AAOIFI standards. Specifically, its interest-bearing debt load is excessive at 1 49.1% of its market cap, and its liquidity ratio is extremely high at 467.2 %, far exceeding the 33% threshold for both metrics.

NOVN — Last 7 Days

DateOpenHighLowCloseVolumeChange
2023-08-210.060.070.050.06114K+0.54%
2023-08-180.060.070.040.05169K-15.57%
2023-08-170.060.070.060.0645K+9.71%
2023-08-160.050.080.050.06184K+11.20%
2023-08-150.050.050.050.05107K+0.00%
2023-08-140.050.060.050.05120K+0.60%
2023-08-110.050.070.050.06124K+9.78%

Discussion

Sign in to join the discussion

Loading comments...

Shariah Screening Details for NOVN

Business Activity

Permissible

Novan passes the business activity screen as its core operations involve developing nitric oxide-based therapies for dermatological conditions like acne and viral skin infections, which are permissible.

Debt / Market Cap

149.08%

Debt: $3.9MThreshold: ≤33%

Interest Income

0.22%

Interest: $53,000Threshold: ≤5%

Cash & Securities

467.18%

Cash: $12.3MThreshold: ≤33%

About Novan, Inc. (NOVN)

Novan, Inc. is a pre-commercial pharmaceutical company specializing in nitric oxide-based therapies for dermatology and anti-infective needs. Their pipeline includes specific candidates like SB204 for acne vulgaris and SB206, a topical anti-viral gel designed to treat viral skin infections. By focusing on proprietary technology to deliver nitric oxide, they aim to address unmet medical needs in treating fungal infections and inflammatory skin diseases .

For Muslim investors using HalalStocks.co.uk, Novan is currently classified as Not Halal (Haram). Although the company's business of creating medicine is permissible, it fails two critical financial screens under AAOIFI standards . The primary issue is the financial structure, where the ratios for both debt and cash holdings relative to market capitalization are significantly higher than the allowed 33% limit.

From a financial perspective, the company carries a debt-to-market cap ratio of 149.1%, indicating a heavy reliance on leverage that is incompatible with Islamic finance principles. Additionally , the company holds a disproportionately large amount of cash and interest-bearing securities compared to its market value (467. 2%), which is common for pre-revenue biotech firms but problematic for shariah compliance. Investors seeking halal options in the biotech sector should look for companies with tighter capital structures and less reliance on interest-based financing.

CEO

Paula Brown Stafford

Employees

90

IPO Date

2016-09-21

Headquarters

Durham, CA, US

NOVN Key Financial Statistics

Revenue

$23.6M

Net Income

$-19.6M

EPS (Diluted)

$-0.89

Stock Price

0.09

Beta

-0.04

52-Week Range

0.082-3.33

Total Debt

$3.9M

Total Equity

$4.6M

Current Ratio

0.91

NOVN Financial Health & Profitability

Profit Margins

Gross Margin68.7%
Operating Margin-149.9%
Net Margin-82.9%

Revenue Growth (YoY)

+736.6%

Prior year: $2.8M

Net Cash

$8.4M

Cash: $12.3M — Debt: $3.9M

R&D Spending

$16.0M

% of Revenue

67.7%

Frequently Asked Questions About NOVN

Is NOVN (Novan, Inc.) stock halal to invest in?
Based on our AAOIFI-standard shariah screening, NOVN is Not Halal (Haram) and is not considered permissible for Muslim investors. It failed 2 of 4 compliance screens. Its debt-to-market-cap ratio of 149.08% exceeds the ≤33% threshold. Its cash & securities ratio of 467.18% exceeds the ≤33% threshold.
What does Novan, Inc. do?
Novan, Inc. is a pre-commercial pharmaceutical company specializing in nitric oxide-based therapies for dermatology and anti-infective needs. Their pipeline includes specific candidates like SB204 for acne vulgaris and SB206, a topical anti-viral gel designed to treat viral skin infections. By focusing on proprietary technology to deliver nitric oxide, they aim to address unmet medical needs in treating fungal infections and inflammatory skin diseases . For Muslim investors using HalalStocks.co.uk, Novan is currently classified as Not Halal (Haram). Although the company's business of creating medicine is permissible, it fails two critical financial screens under AAOIFI standards . The primary issue is the financial structure, where the ratios for both debt and cash holdings relative to market capitalization are significantly higher than the allowed 33% limit. From a financial perspective, the company carries a debt-to-market cap ratio of 149.1%, indicating a heavy reliance on leverage that is incompatible with Islamic finance principles. Additionally , the company holds a disproportionately large amount of cash and interest-bearing securities compared to its market value (467. 2%), which is common for pre-revenue biotech firms but problematic for shariah compliance. Investors seeking halal options in the biotech sector should look for companies with tighter capital structures and less reliance on interest-based financing. Novan, Inc. operates in the Healthcare sector under the Biotechnology industry and is headquartered in Durham, CA, US. The company is led by CEO Paula Brown Stafford and employs approximately 90 people.
What screening criteria were used for NOVN?
NOVN was screened using AAOIFI-based shariah compliance criteria. Four tests are applied: (1) Business Activity — the company's core business must not derive primary income from haram (prohibited) activities such as alcohol, gambling, tobacco, or interest-based finance. (2) Debt-to-Market-Cap — total debt must not exceed 33% of market capitalization. (3) Interest Income — interest income must not exceed 5% of total revenue. (4) Cash & Securities — cash and interest-bearing securities must not exceed 33% of market cap. NOVN passed 2 of these 4 screens.
When was NOVN last screened?
NOVN was last screened on 2026-02-24. Shariah compliance status can change as companies report new financial data, acquire new businesses, or shift revenue streams. We recommend checking back periodically for the most up-to-date screening results.

Disclaimer

This shariah compliance assessment for NOVN (Novan, Inc.) is provided for informational purposes only and does not constitute financial, investment, or religious advice. Screening criteria are based on widely accepted AAOIFI standards, but individual scholars may differ in their opinions. Always consult with a qualified Islamic scholar and licensed financial advisor before making investment decisions. Past screening status does not guarantee future compliance. Last screened: 2026-02-24.

Other Screened Stocks in Healthcare